| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8458189 | Pathology - Research and Practice | 2018 | 27 Pages |
Abstract
Survivin (BIRC5) expression might become a specific but low-sensitivity biomarker in ovarian cancer patients, and its presence indicated poor prognosis and worse TNM stages. This protein might function as an oncoprotein by influencing specific pathways involving the 50 genes identified herein. Additional studies are needed to confirm these results.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Xiao-jiao Li, Jin-shu Pang, Yao-mei Li, Farah Abdirahman Ahmed, Rong-quan He, Jie Ma, Fu-chao Ma, Gang Chen,